Heteroresistance to penicillin in Streptococcus pneumoniae.
Heteroresistance to beta-lactam antibiotics has been mainly described for staphylococci, for which it complicates diagnostic procedures and therapeutic success. This study investigated whether heteroresistance to penicillin exists in Streptococcus pneumoniae. Population analysis profile (PAP) showed the presence of subpopulations with higher penicillin resistance in four of nine clinical pneumococcal strains obtained from a local surveillance program (representing the multiresistant clones ST179, ST276, and ST344) and in seven of 16 reference strains (representing the international clones Spain(23F)-1, Spain(9V)-3, Spain(14)-5, Hungary(19A)-6, South Africa(19A)-13, Taiwan(23F)-15, and Finland(6B)-12). Heteroresistant strains had penicillin minimal inhibitory concentrations (MICs) (for the majority of cells) in the intermediate- to high-level range (0.19-2.0 mug/ml). PAP curves suggested the presence of subpopulations also for the highly penicillin-resistant strains Taiwan(19F)-14, Poland(23F)-16, CSR(19A)-11, and CSR(14)-10. PAP of bacterial subpopulations with higher penicillin resistance showed a shift toward higher penicillin-resistance levels, which reverted upon multiple passages on antibiotic-free media. Convergence to a homotypic resistance phenotype did not occur. Comparison of two strains of clone ST179 showed a correlation between the heteroresistant phenotype and a higher-penicillin MIC and a greater number of altered penicillin-binding proteins (PBP1a, -2b, and -2x), respectively. Therefore, heteroresistance to penicillin occurs in international multiresistant clones of S. pneumoniae. Pneumococci may use heteroresistance to penicillin as a tool during their evolution to high penicillin resistance, because it gives the bacteria an opportunity to explore growth in the presence of antibiotics before acquisition of resistance genes.
Morand
Brigitte
B
Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51, 3010 Bern, Switzerland.
Mühlemann
Kathrin
K
D024881:Drug Resistance, Bacterial; D005843:Geography; D006461:Hemolysis; D006801:Humans; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010406:Penicillins / Q000494:pharmacology*; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification
D010406:Penicillins
J Clin Microbiol. 2006 Jun;44(6):2032-8
16757594
Antimicrob Agents Chemother. 2006 Sep;50(9):2946-50
16940086
J Clin Microbiol. 2001 Sep;39(9):3379-81
11526184
J Bacteriol. 2004 Jun;186(12):3721-9
15175285
J Exp Med. 1944 Feb 1;79(2):137-58
19871359
Antimicrob Agents Chemother. 2006 Dec;50(12):4062-9
17000738
J Bacteriol. 1989 Feb;171(2):874-9
2536684
Antimicrob Agents Chemother. 1986 Jan;29(1):85-92
3488015
J Med Microbiol. 2003 Aug;52(Pt 8):605-7
12867551
Antimicrob Agents Chemother. 2002 Jan;46(1):24-30
11751106
Antimicrob Agents Chemother. 2006 Dec;50(12):4053-61
17000741
Antimicrob Agents Chemother. 1994 Nov;38(11):2590-8
7872753
Microbiology. 1998 Nov;144 ( Pt 11):3049-60
9846740
Antimicrob Agents Chemother. 2004 Sep;48(9):3563-6
15328127
J Infect Dis. 2006 May 1;193(9):1296-303
16586368
Mol Microbiol. 1999 Aug;33(4):673-8
10447877
J Antimicrob Chemother. 2001 Apr;47(4):399-403
11266410
Mol Microbiol. 1994 May;12(3):505-15
8065267
Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S13-8
8477757
Mol Microbiol. 1993 Aug;9(3):635-43
8412708
Antimicrob Agents Chemother. 1991 Jan;35(1):124-9
2014967
J Clin Microbiol. 2003 Jan;41(1):267-72
12517859
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1550-5
11830670
J Infect Dis. 2003 Feb 15;187(4):589-96
12599075
J Clin Microbiol. 2001 Jul;39(7):2565-71
11427569
Proc Natl Acad Sci U S A. 1989 Nov;86(22):8842-6
2813426
Int J Tuberc Lung Dis. 2001 Apr;5(4):339-45
11334252
J Infect Dis. 2000 Oct;182(4):1153-60
10979912
Antimicrob Agents Chemother. 1994 Apr;38(4):724-8
8031036
J Antimicrob Chemother. 2002 Dec;50 Suppl S2:1-5
12556427
J Clin Microbiol. 2005 Sep;43(9):4696-703
16145129